According to Medifast's latest financial reports the company's current EPS (TTM) is โน1,039. In 2022 the company made an earnings per share (EPS) of โน1,090 a decrease over its 2021 EPS that were of โน1,193.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน1,002 | -8.12% |
2022 | โน1,090 | -8.63% |
2021 | โน1,193 | 60.41% |
2020 | โน743.99 | 32.02% |
2019 | โน563.53 | 42.06% |
2018 | โน396.68 | 100% |
2017 | โน198.34 | 54.3% |
2016 | โน128.54 | -9.04% |
2015 | โน141.31 | 66% |
2014 | โน85.12 | -42.53% |
2013 | โน148.12 | 50% |
2012 | โน98.75 | -12.12% |
2011 | โน112.37 | -5.71% |
2010 | โน119.18 | 66.67% |
2009 | โน71.51 | 127.03% |
2008 | โน31.50 | 23.33% |
2007 | โน25.54 | -18.92% |
2006 | โน31.50 | 68.18% |
2005 | โน18.73 | 37.5% |
2004 | โน13.62 | -36% |
2003 | โน21.28 | -30.56% |
2002 | โน30.64 | 350% |
2001 | โน6.81 | -57.89% |
2000 | โน16.17 |